Engaging stakeholders to design a comparative effectiveness trial in children with uncontrolled asthma

Kim Erwin*, Molly A. Martin, Tara Flippin, Sarah Norell, Ariana Shadlyn, Jie Yang, Paula Falco, Jaime Rivera, Stacy Ignoffo, Rajesh Kumar, Helen Margellos-Anast, Michael McDermott, Kate McMahon, Giselle Mosnaim, Sharmilee M. Nyenhuis, Valerie G. Press, Jessica E. Ramsay, Kenneth Soyemi, Trevonne M. Thompson, Jerry A. Krishnan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Aim: To present the methods and outcomes of stakeholder engagement in the development of interventions for children presenting to the emergency department (ED) for uncontrolled asthma. Methods: We engaged stakeholders (caregivers, physicians, nurses, administrators) from six EDs in a three-phase process to: define design requirements; prototype and refine; and evaluate. Results: Interviews among 28 stakeholders yielded themes regarding in-home asthma management practices and ED discharge experiences. Quantitative and qualitative evaluation showed strong preference for the new discharge tool over current tools. Conclusion: Engaging end-users in contextual inquiry resulted in CAPE (CHICAGO Action Plan after ED discharge), a new stakeholder-balanced discharge tool, which is being tested in a multicenter comparative effectiveness trial.

Original languageEnglish (US)
Pages (from-to)17-30
Number of pages14
JournalJournal of Comparative Effectiveness Research
Volume5
Issue number1
DOIs
StatePublished - Jan 2016

Funding

The authors gratefully acknowledge the help of T MacTavish, IIT Institute of Design; JT Senko, JH Stroger, Jr Hospital of Cook County; CJ Lohff, Chicago Department of Public Health; ZE Pittsenbarger, Ann and Robert H Lurie Children''s Hospital of Chicago; J E Kramer, Rush University Medical Center; H Margellos-Anast, LS Zun, Mount Sinai Hospital; SM Paik and J Solway, University of Chicago; ML Berbaum, N Bracken, and HA Gussin, for their role in the development of the CHICAGO comparative effectiveness trial. The authors thank L Sanker for her help in the development and conduct of focus groups. The authors also thank the families and the staff in the CHICAGO ED clinical centers and partner organizations who contributed their time to make this study possible. The study was sponsored by the Patient-Centered Outcomes Research Institute (contract #AS-1307-05420). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or fi­nancial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. The authors gratefully acknowledge the help of T MacTavish, IIT Institute of Design; JT Senko, JH Stroger, Jr Hospital of Cook County; CJ Lohff, Chicago Department of Public Health; ZE Pittsenbarger, Ann and Robert H Lurie Children''s Hospital of Chicago; J E Kramer, Rush University Medical Center; H Margellos-Anast, LS Zun, Mount Sinai Hospital; SM Paik and J Solway, University of Chicago; ML Berbaum, N Bracken, and HA Gussin, for their role in the development of the CHICAGO comparative effectiveness trial. The authors thank L Sanker for her help in the development and conduct of focus groups. The authors also thank the families and the staff in the CHICAGO ED clinical centers and partner organizations who contributed their time to make this study possible. The study was sponsored by the Patient-Centered Outcomes Research Institute (contract #AS-1307-05420). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or fi?nancial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Keywords

  • asthma
  • health communication
  • patient discharge
  • pediatrics
  • stakeholder engagement
  • written action plan

ASJC Scopus subject areas

  • Health Policy

Fingerprint

Dive into the research topics of 'Engaging stakeholders to design a comparative effectiveness trial in children with uncontrolled asthma'. Together they form a unique fingerprint.

Cite this